{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:35:59Z","timestamp":1788910559108,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.plefa.2020.102056","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:37:50Z","timestamp":1579693070000},"page":"102056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Altered plasma prostaglandin E2 levels in epilepsy and in response to antiepileptic drug monotherapy"],"prefix":"10.1016","volume":"153","author":[{"given":"Chitra","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shivangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achal K","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritushree","family":"Kukreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2020.102056_bib0001","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.plefa.2020.102056_bib0002","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4103\/0028-3886.149365","article-title":"Epidemiology of neurological disorders in India: review of background, prevalence and incidence of epilepsy, stroke, Parkinson's disease and tremors","volume":"62","author":"Gourie-Devi","year":"2014","journal-title":"Neurol. India"},{"key":"10.1016\/j.plefa.2020.102056_bib0003","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1535-7511.2010.01383.x","article-title":"Intractable epilepsy: relapsing, remitting, or progressive?","volume":"10","author":"Herman","year":"2010","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.plefa.2020.102056_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.plefa.2020.102056_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.plefa.2020.102056_bib0006","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1749-6632.1989.tb22619.x","article-title":"Arachidonic acid metabolism in seizures","volume":"559","author":"Siesj\u00f6","year":"1989","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.plefa.2020.102056_bib0007","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.eplepsyres.2011.10.034","article-title":"Eicosanoid levels in the neocortex of drug-resistant epileptic patients submitted to epilepsy surgery","volume":"99","author":"Rumi\u00e0","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.plefa.2020.102056_bib0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fnmol.2018.00067","article-title":"Antiepileptogenic effect of subchronic palmitoylethanolamide treatment in a mouse model of acute epilepsy","volume":"11","author":"Post","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.plefa.2020.102056_bib0009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12974-019-1592-3","article-title":"Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management","volume":"16","author":"Rawat","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.plefa.2020.102056_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1098-8823(03)00040-6","article-title":"Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling","volume":"71","author":"Takemiya","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.plefa.2020.102056_bib0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eplepsyres.2007.12.008","article-title":"Cyclooxygenase-2\/PGE2 pathway facilitates pentylenetetrazol-induced seizures","volume":"79","author":"Oliveira","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.plefa.2020.102056_bib0012","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1528-1167.2010.02585.x","article-title":"Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?","volume":"51","author":"Potschka","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.plefa.2020.102056_bib0013","series-title":"Physical Activity","year":"2015"},{"key":"10.1016\/j.plefa.2020.102056_bib0014","article-title":"Peripheral blood gene expression signatures associated with epilepsy and its etiologic classification","author":"Rawat","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.plefa.2020.102056_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.plefa.2020.102056_bib0016","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.plefa.2020.102056_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1167.2008.01716.x","article-title":"The clinical impact of pharmacogenetics on the treatment of epilepsy","volume":"50","author":"L\u00f6scher","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.plefa.2020.102056_bib0018","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.plefa.2020.102056_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00001756-199501000-00005","article-title":"Expression of cyclo-oxygenase 2 in rat brain following kainate treatment","volume":"6","author":"Chen","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.plefa.2020.102056_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1471-4159.1996.66010006.x","article-title":"Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation","volume":"66","author":"Adams","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plefa.2020.102056_bib0021","doi-asserted-by":"crossref","first-page":"24794","DOI":"10.1074\/jbc.271.40.24794","article-title":"Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist","volume":"271","author":"Marcheselli","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2020.102056_bib0022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(95)11839-O","article-title":"Prostaglandin E2 stimulates glutamate release from synaptosomes of rat spinal cord","volume":"196","author":"Nishihara","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.plefa.2020.102056_bib0023","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1523\/JNEUROSCI.2392-05.2005","article-title":"Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor","volume":"25","author":"Sang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.plefa.2020.102056_bib0024","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2005.05.038","article-title":"Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus","volume":"1050","author":"Kawaguchi","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.plefa.2020.102056_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neures.2006.06.003","article-title":"Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region","volume":"56","author":"Takemiya","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.plefa.2020.102056_bib0026","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1600-0404.2003.00253.x","article-title":"Valproic acid blood genomic expression patterns in children with epilepsy\u2014a pilot study","volume":"109","author":"Tang","year":"2004","journal-title":"Acta. Neurol. Scand."},{"key":"10.1016\/j.plefa.2020.102056_bib0027","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1471-4159.2003.01701.x","article-title":"Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain","volume":"85","author":"Bosetti","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plefa.2020.102056_bib0028","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1399-5618.2007.00361.x","article-title":"Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappab DNA binding activity and COX-2 mRNA","volume":"9","author":"Rao","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.plefa.2020.102056_bib0029","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bcp.2014.02.004","article-title":"Valproic acid suppresses lipopolysaccharide-induced cyclooxygenase-2 expression via MKP-1 in murine brain microvascular endothelial cells","volume":"88","author":"Chuang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2020.102056_bib0030","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","article-title":"Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling","volume":"73","author":"Bauer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.plefa.2020.102056_bib0031","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1021\/mp4001102","article-title":"Dynamic regulation of P-glycoprotein in human brain capillaries","volume":"10","author":"Avemary","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.plefa.2020.102056_bib0032","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neuropharm.2009.01.009","article-title":"Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition","volume":"56","author":"Zibell","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.plefa.2020.102056_bib0033","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2009.09.012","article-title":"COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats","volume":"58","author":"van Vliet","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.plefa.2020.102056_bib0034","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.2010.00765.x","article-title":"Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy","volume":"160","author":"Schlichtiger","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2020.102056_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10787-006-1535-3","article-title":"Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice","volume":"14","author":"Dhir","year":"2006","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.plefa.2020.102056_bib0036","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/phrs.1998.0309","article-title":"Effect of non-steroidal anti-inflammatory drugs on the anticonvulsive activity of valproate and diphenylhydantoin against maximal electroshock-induced seizures in mice","volume":"37","author":"Kaminski","year":"1998","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.plefa.2020.102056_bib0037","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/0883073810388646","article-title":"Survey of aspirin use in Sturge-Weber syndrome","volume":"26","author":"Bay","year":"2011","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.plefa.2020.102056_bib0038","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0883073812463607","article-title":"Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes","volume":"28","author":"Lance","year":"2013","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.plefa.2020.102056_bib0039","first-page":"879","article-title":"The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy","volume":"44","author":"Bazan","year":"1986","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.plefa.2020.102056_bib0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s004240100572","article-title":"Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain","volume":"442","author":"Davidson","year":"2001","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.plefa.2020.102056_bib0041","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1523\/JNEUROSCI.3846-16.2017","article-title":"Immune-Induced fever is dependent on local but not generalized prostaglandin E2 synthesis in the brain","volume":"37","author":"Eskilsson","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.plefa.2020.102056_bib0042","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/jpet.302.3.846","article-title":"Pharmacology of celecoxib in rat brain after kainate administration","volume":"302","author":"Ciceri","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plefa.2020.102056_bib0043","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00007691-200210000-00005","article-title":"Comparison of an Elisa and an LC\/MS\/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients","volume":"24","author":"Staatz","year":"2002","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.plefa.2020.102056_bib0044","doi-asserted-by":"crossref","first-page":"FSO157","DOI":"10.4155\/fsoa-2016-0067","article-title":"Quantitative analysis of lipids: a higher-throughput LC-MS\/MS-based method and its comparison to Elisa","volume":"3","author":"Gandhi","year":"2017","journal-title":"Future Sci. OA"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327819301693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327819301693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:08:01Z","timestamp":1760602081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327819301693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":44,"alternative-id":["S0952327819301693"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2020.102056","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered plasma prostaglandin E2 levels in epilepsy and in response to antiepileptic drug monotherapy","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2020.102056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102056"}}